Cipher Pharmaceuticals (OTCMKTS:CPHRF) Shares Pass Above 50-Day Moving Average of $2.37

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRFGet Rating) (TSE:CPH)’s share price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $2.37 and traded as high as $2.56. Cipher Pharmaceuticals shares last traded at $2.52, with a volume of 15,500 shares.

Cipher Pharmaceuticals Stock Down 0.8 %

The stock’s fifty day simple moving average is $2.37 and its 200 day simple moving average is $2.02.

About Cipher Pharmaceuticals

(Get Rating)

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream that reduces the growth of unwanted facial hair in women; BRINAVESS, a treatment for sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet drug.

See Also

Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.